ASPSCR1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: The distinct genomic features of ASPSCR1-TFE3 fusion tRCC identified in the current study suggested a molecular basis for the aggressive nature of this TFE3-tRCC subtype.